Rodriguez-Sierra J F, Sridaran R, Blake C A
Neuroendocrinology. 1980 Sep;31(3):228-35. doi: 10.1159/000123079.
Experiments were conducted to determine the effects of neonatal administration of L-monosodium glutamate (MSG) on behavioral and endocrine function in the female rat. Administration of MSG (4 mg/kg body weight) at days 1, 3, 5, 7 and 9 in neonates results in a delay of vaginal opening (VO) and the absence of ovulation at the time of VO. However, some rats were observed to ovulate after VO if they were subjected to sequential laparotomies. MSG-treated rats also fail to exhibit compensatory ovarian hypertrophy. Ovariectomized MSG-treated rats injected with estradiol benzoate (EB) followed by a progesterone injected 2 days later did not exhibit sexual beahvior to male rats, while all the control rats displayed lordosis. Chronic treatment with EB for 12 days, followed by a progesterone injection on the 12th day, resulted in a marked improvement of the sexual receptivity of the MSG-treated rats. The body weight of the MSG-treated animals was lower than that of the controls during development although the MSG animals looked obese. Food intake is normal in the MSG-treated rats, but when expressed as intake/100 g body weight, the MSG-treated rats appeared slightly hyperphagic, MSG-treated rats respond with increased food intake after ovariectomy and EB treatment suppresses the increased food intake. Thus, the control of food intake by estrogen does not seem to be affected by the MSG treatment; in fact, these animals seem to be more sensitive than control rats to the anorectic effects of EB. Neonatal MSG treatment appears to affect the neural control for the tonic secretion of gonadotropins by destroying arcuate nuclei. This undoubtedly reduces the reproductive capacity of the animals by impeding the growth and secretions of their ovaries. The findings that chronic estrogen followed by progesterone treatment can reinstate sexual receptivity in MSG-treated animals suggests that the arcuate nuclei are not needed for the expression of sexual behavior and that estrogens might remedy the fertility problems of MSG-treated animals.
进行了实验以确定新生大鼠给予L-谷氨酸单钠(MSG)对其行为和内分泌功能的影响。在新生大鼠出生后第1、3、5、7和9天给予MSG(4mg/kg体重),会导致阴道开口(VO)延迟,且在VO时无排卵现象。然而,如果对一些大鼠进行连续剖腹手术,观察到它们在VO后会排卵。经MSG处理的大鼠也未表现出代偿性卵巢肥大。对去卵巢的经MSG处理的大鼠注射苯甲酸雌二醇(EB),然后在2天后注射孕酮,这些大鼠对雄性大鼠未表现出性行为,而所有对照大鼠都表现出脊柱前凸。用EB慢性治疗12天,然后在第12天注射孕酮,可使经MSG处理的大鼠的性接受能力显著改善。在发育过程中,经MSG处理的动物体重低于对照组,尽管这些经MSG处理的动物看起来肥胖。经MSG处理的大鼠食物摄入量正常,但以每100g体重摄入量表示时,经MSG处理的大鼠似乎略有食欲亢进,经MSG处理的大鼠在去卵巢后食物摄入量增加,而EB处理可抑制这种增加的食物摄入量。因此,雌激素对食物摄入的控制似乎不受MSG处理的影响;事实上,这些动物似乎比对照大鼠对EB的厌食作用更敏感。新生期MSG处理似乎通过破坏弓状核来影响促性腺激素的紧张性分泌的神经控制。这无疑通过阻碍卵巢的生长和分泌而降低了动物的生殖能力。慢性雌激素随后用孕酮治疗可恢复经MSG处理动物的性接受能力,这一发现表明弓状核对于性行为的表达并非必需,并且雌激素可能弥补经MSG处理动物的生育问题。